0
Articles   |    
Oral Pentoxifylline Inhibits Release of Tumor Necrosis Factor-Alpha from Human Peripheral Blood Monocytes A Potential Treatment for Aseptic Loosening of Total Joint Components
Paul F. Pollice, MD; Randy N. Rosier, MD, PhD; R. John Looney, MD; J. Edward Puzas, PhD; Edward M. Schwarz, PhD; Regis J. O’Keefe, MD, PhD
View Disclosures and Other Information
Investigation performed at the University of Rochester Medical Center, Rochester, New York
Paul F. Pollice, MD
Randy N. Rosier, MD, PhD
R. John Looney, MD
J. Edward Puzas, PhD
Edward M. Schwarz, PhD
Regis J. O’Keefe, MD, PhD
Department of Orthopaedics (P.F.P., R.N.R., J.E.P., E.M.S., and R.J.O’K.), Box 665, and Department of Medicine (R.J.L.), University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642. E-mail address for R.J. O’Keefe: regis_okeefe@urmc.rochester.edu

One or more of the authors may receive benefits for personal or professional use from a commercial party related directly or indirectly to the subject of this article. Two of the authors hold a United States patent for the use of phosphodiesterase inhibitors to prevent inflammatory bone resorption. There are no current commercial interests and there have been no discussions or relationships with commercial parties concerning this. P.F. Pollice was awarded a 2000 American Orthopaedic Association/Zimmer Resident Travel Award for this work. The work was supported by Public Health Service Awards AR46545 (R.J.O’K.) and AR44220 (R.J.O’K.) from the National Institutes of Health.

J Bone Joint Surg Am, 2001 Jul 01;83(7):1057-1061
5 Recommendations (Recommend) | 3 Comments | Saved by 3 Users Save Case

Abstract

Background: Pentoxifylline (Trental) is a methylxanthine-derivative drug that has been used for more than twenty years in the treatment of peripheral vascular disease. Pentoxifylline is also a potent inhibitor of tumor necrosis factor-alpha (TNF-a) secretion, both in vitro and in vivo, and has demonstrated efficacy in the treatment of certain animal and human inflammatory diseases. Pentoxifylline has a potential therapeutic role in the treatment of aseptic loosening of total joint replacement components because it inhibits TNF-a secretion by particle-stimulated human peripheral blood monocytes. The purpose of our study was to determine whether the particle-stimulated secretion of TNF-a by peripheral blood monocytes was inhibited in volunteers who had received pentoxifylline orally.

Methods: Human peripheral blood monocytes were harvested from eight healthy volunteers and were exposed to three different concentrations of titanium particles or to 500 ng/mL of lipopolysaccharide as a positive control. The same volunteers were then given pentoxifylline (400 mg, five times per day) for seven days. Their peripheral blood monocytes were again isolated and exposed to experimental conditions, and the TNF-a levels were measured.

Results: The peripheral blood monocytes from all eight volunteers showed a significant reduction in TNF-a release following oral treatment with pentoxifylline. This reduction was observed at exposures of 107 and 106 titanium particles/mL and in the lipopolysaccharide-treated group, but not at 105 particles/mL.

Conclusions: To our knowledge, this is the first study to demonstrate the ability of an oral drug to decrease the release of TNF-a from human peripheral blood monocytes exposed ex vivo to particle debris. TNF-a is involved in the pathogenesis of osteolysis and subsequent loosening of total joint arthroplasty components. The ability to suppress the release of TNF-a in patients with a total joint replacement may help to control osteolysis and to reduce the development of aseptic loosening. This effect could increase implant longevity and decrease the need for revision arthroplasty.

Figures in this Article
    Sign In to Your Personal ProfileSign In To Access Full Content
    Not a Subscriber?
    Get online access for 30 days for $35
    New to JBJS?
    Sign up for a full subscription to both the print and online editions
    Register for a FREE limited account to get full access to all CME activities, to comment on public articles, or to sign up for alerts.
    Register for a FREE limited account to get full access to all CME activities
    Have a subscription to the print edition?
    Current subscribers to The Journal of Bone & Joint Surgery in either the print or quarterly DVD formats receive free online access to JBJS.org.
    Forgot your password?
    Enter your username and email address. We'll send you a reminder to the email address on record.

     
    Forgot your username or need assistance? Please contact customer service at subs@jbjs.org. If your access is provided
    by your institution, please contact you librarian or administrator for username and password information. Institutional
    administrators, to reset your institution's master username or password, please contact subs@jbjs.org

    References

    Accreditation Statement
    These activities have been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the American Academy of Orthopaedic Surgeons and The Journal of Bone and Joint Surgery, Inc. The American Academy of Orthopaedic Surgeons is accredited by the ACCME to provide continuing medical education for physicians.
    CME Activities Associated with This Article
    Submit a Comment
    Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
    Comments are moderated and will appear on the site at the discretion of JBJS editorial staff.

    * = Required Field
    (if multiple authors, separate names by comma)
    Example: John Doe





    Related Content
    The Journal of Bone & Joint Surgery
    JBJS Case Connector
    Topic Collections
    Related Audio and Videos
    PubMed Articles
    Clinical Trials
    Readers of This Also Read...
    JBJS Jobs
    01/22/2014
    PA - Penn State Milton S. Hershey Medical Center
    04/02/2014
    WY - Memorial Hospital of Sweetwater County
    02/28/2014
    DC - Children's National Medical Center